1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA)/ Yolanda Rosser conducted a case management visit to follow-up on an incident report dated 5/8/24. LPA Rosser met with Administrator/ Chanel Ann Sanchez and explained the purpose of today's visit.
The incident report was regarding 50 missing Oxycodone 325 mg tablets belonging to Resident #1 (R1) and subsequent police visit regarding the missing medication. LPA Rosser interviewed the Administrator/ Chanel Ann Sanchez, LVN/ Shirley Gonzalez, and Resident #1 (R1). LPA Rosser obtained copies of R1's facility file, medication administration Records for April 2024-June 2024, narcotic count audit forms, police incident report number, and Medical-Technician training verification.
LPA Rosser found R#1 handles all medical and ordering medications independently. LPA found R#1 places orders for a surplus for Oxycodone 325 mg. The facility stores R#1’s medication and administered medications to R#1 who experiences a chronic pain condition. LPA Rosser found the facility conducts medication audits during shift changes as a measure to safeguard medication. The audits are conducted by the incoming Medical Technician and outgoing Medical-Technician at the end of shifts. The audits did not include the surplus medications as they are not administered until a depletion of medication occurs. On 5/7/24, a medication audit of surplus medication occurred, and 50 Oxycodone 325 mg tablets were missing from R#1’s surplus and on 5/8/24 an audit was conducted, and 195 Oxycodone 325 mg tablets were missing from R#1’s surplus. On 5/9/24 law enforcement was notified of the missing tablets and visited the facility on 5/9/24. The police department recorded the incident and no follow-up occurred. LPA Rosser found the department did not receive an Unusual Incident Report was submitted for the 5/8/24 audit results and missing tablets.
|